All In MedTech

Device Trial Radar · NCT07325552

iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment

iStent Inject Versus Goniotomy With Kahook Dual Blade in Patients With Ocular Hypertension and Glaucoma

Last checked: Nov 19, 2026Latest source record: Jan 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Jan 1, 2026

Primary completion

Jan 1, 2027

Study completion Jan 1, 2028

Sponsor

Lead sponsor
Medical University of BialystokAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 8, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 weeks
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to investigate the efficacy of cataract surgery in combination with Kahook Dual Blade Glide goniotomy (KDB) or iStent Inject W Trabecular Microbypass Stent (Istent) in eyes with Open-angle glaucoma.

Conditions

  • Open Angle Glaucoma (OAG)

Interventions

  • Goniotomy with KDB blade goniotomyDevice

    Goniotomy with KDB glide will be performed at the end of Cataract Surgery through the temporal cataract incision.

  • Two iStent inject implanationDevice

    The two stents will be injected in Schlemms canal at the end of cataract surgery through the temporal cataract incision.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in the number of intraocular pressure lowering medications compared to baselineTime frame: From enrollment to the end of treatment at 12 months
  2. Intraocular pressure measured by Goldmann applanation tonometry (GAT)Time frame: From enrollment to the end of treatment at 12 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Ophthalmology Clinic Medical University of Bialystok

    Bialystok, Poland · Recruiting

  • Medical University of Bialystok

    Bialystok, Polska, Poland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.